quinidine has been researched along with Torsade de Pointes in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 24 (52.17) | 18.2507 |
2000's | 10 (21.74) | 29.6817 |
2010's | 9 (19.57) | 24.3611 |
2020's | 3 (6.52) | 2.80 |
Authors | Studies |
---|---|
Cooper, J; Cui, Y; Fink, M; Gavaghan, DJ; Heath, BM; McMahon, NC; Mirams, GR; Noble, D; Sher, A | 1 |
Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
Kawai, T; Kuninishi, Y; Muraki, Y; Nogawa, H | 1 |
Bastogne, T; Champéroux, P; Fares, R; Le Guennec, JY; Richard, S; Thireau, J | 1 |
Marai, I; Rosso, R; Viskin, S | 1 |
Hamlin, RL; Kijtawornrat, A; Limprasutr, V; Meedech, P; Saengklub, N | 1 |
Dumotier, B; Guérard, N; Jordaan, P | 1 |
Antzelevitch, C; Belardinelli, L; Guo, D; Hackett, J; Jiao, Z; Li, H; Shryock, JC; Wu, L; Yan, GX | 1 |
Overholser, BR; Sowinski, KM; Tisdale, JE; Wroblewski, HA | 1 |
Ciaccio, EJ | 1 |
Kingery, JR; Kovacs, RJ; Overholser, BR; Tisdale, JE; Wroblewski, HA | 1 |
Hamlin, RL; Kijtawornrat, A; Sawangkoon, S | 1 |
El-Eraky, H; Thomas, SH | 1 |
Tsai, CL | 1 |
Roden, DM | 2 |
Hamlin, RL; Keene, BW; Kijtawornrat, A; Nishijima, Y; Roche, BM | 1 |
Dolgosheĭ, TS; Kokhkovski, AB; Liskovich, TG; Madeshkina, GA; Mironchik, EV; Tyshchenko, AD | 1 |
Futterman, LG; Lemberg, L | 1 |
Bursill, JA; Campbell, TJ; Wyse, KR | 1 |
Bauman, JL; Gallastegui, JL; O'Toole, MF; Oberg, KC | 1 |
Bhutto, ZR; Buckingham, TA; Telfer, EA; Zbilut, J | 1 |
Faber, TS; Hohnloser, S; Just, H; Van de Loo, A; Zehender, M | 1 |
Fromm, BS; Lehmann, MH; Makkar, RR; Meissner, MD; Steinman, RT | 1 |
Roden, DM; Yang, T | 1 |
Darius, H; Genth, S; Himmrich, E; Meyer, J; Treese, N; Zotz, R | 1 |
Asano, Y; Baxter, WT; Davidenko, JM; Gray, RA; Jalife, J | 1 |
Karch, M; Plewan, A; Schmidt, G; Schmitt, C; Schömig, A | 1 |
Chow, MS; Kluger, J; Tran, HT | 1 |
Cheymol, G; Chézalviel-Guilbert, F; Davy, JM; Deplanne, V; Poirier, JM; Weissenburger, J; Xia, YZ | 1 |
Antzelevitch, C; Burashnikov, A; Di Diego, J; Nesterenko, VV; Saffitz, J; Shimizu, W; Sicouri, S; Thomas, GP; Weissenburger, J; Yan, GX | 1 |
Shivkumar, K | 1 |
De Clerck, F; Lu, HR; Remeysen, P | 1 |
Imai, R; Tamura, T; Yamamoto, K; Yamamoto, M | 1 |
Farkas, A; Leprán, I; Papp, JG | 1 |
Duff, HJ; Gillis, AM; Hii, JT; Mitchell, LB; Solylo, MA; Wyse, DG | 1 |
Inoue, H; Sugimoto, T | 1 |
Cohen, JM; Gillis, AM; Hii, JT; Mitchell, LB; Wyse, DG | 1 |
Renz, T | 1 |
Alves, PA; Bassan, R; Dohmann, HF; Fernandes, PH; Guarçoni, O; Maia, IG; Ribeiro, JC; Sá, R | 1 |
Aarons, D; Alicea, AE; Veltri, EP | 1 |
Bando, S; Hamai, K; Ikefuji, H; Ito, S; Nishikado, A; Shinohara, A; Yamamoto, H; Yamamoto, K | 1 |
Bando, S; Hamai, K; Nishikado, A; Shinohara, A; Yamamoto, H; Yamamoto, K | 1 |
Bando, S; Fujino, K; Hamai, K; Nakaya, Y; Nishikado, A; Shinohara, A; Yamamoto, H | 1 |
Arfiero, S; Ometto, R; Vincenzi, M | 1 |
4 review(s) available for quinidine and Torsade de Pointes
Article | Year |
---|---|
Long QT syndrome: reduced repolarization reserve and the genetic link.
Topics: Anti-Arrhythmia Agents; Disease Susceptibility; Female; Genotype; Histamine H1 Antagonists; Humans; Long QT Syndrome; Male; Polymorphism, Genetic; Quinidine; Risk Factors; Terfenadine; Torsades de Pointes | 2006 |
Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Bepridil; Cardiovascular Agents; Disopyramide; Female; Humans; Male; Middle Aged; Prenylamine; Procainamide; Quinidine; Risk Factors; Sex; Sotalol; Syncope; Tachycardia, Ventricular; Torsades de Pointes | 1993 |
Is there a need for new antiarrhythmic drugs?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Conduction System; Humans; Propafenone; Quinidine; Sotalol; Torsades de Pointes | 1996 |
The M cell: its contribution to the ECG and to normal and abnormal electrical function of the heart.
Topics: Action Potentials; Animals; Electrocardiography; Enzyme Inhibitors; Heart Rate; Heart Ventricles; Humans; Ion Channels; Long QT Syndrome; Myocardium; Patch-Clamp Techniques; Quinidine; Torsades de Pointes | 1999 |
1 trial(s) available for quinidine and Torsade de Pointes
Article | Year |
---|---|
Effects of sex on the pharmacokinetic and pharmacodynamic properties of quinidine.
Topics: Administration, Oral; Adolescent; Adult; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Quinidine; Sex Characteristics; Torsades de Pointes | 2003 |
41 other study(ies) available for quinidine and Torsade de Pointes
Article | Year |
---|---|
Simulation of multiple ion channel block provides improved early prediction of compounds' clinical torsadogenic risk.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Computer Simulation; Dogs; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Guinea Pigs; HEK293 Cells; Humans; Ion Channels; Kinetics; Models, Cardiovascular; NAV1.5 Voltage-Gated Sodium Channel; Patch-Clamp Techniques; Potassium Channel Blockers; Rabbits; Risk Assessment; Risk Factors; Sodium Channel Blockers; Sodium Channels; Torsades de Pointes; Transfection | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
Pharmacological characterisation of electrocardiogram J-T
Topics: Animals; DNA-Binding Proteins; Electrocardiography; Flecainide; Guinea Pigs; Long QT Syndrome; Nifedipine; Quinidine; Quinine; Ranolazine; Sotalol; Torsades de Pointes; Verapamil | 2022 |
Contribution of haemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
Topics: Animals; Arrhythmias, Cardiac; Dogs; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Ether-A-Go-Go Potassium Channels; Heart Rate; Long QT Syndrome; Moxifloxacin; Quinidine; Reflex; Torsades de Pointes | 2022 |
Long QT Syndrome and Torsade de Pointes Ultimately Treated With Quinidine: Introducing the Concept of Pseudo-Torsade de Pointes.
Topics: Adrenergic alpha-Antagonists; Adult; Diagnosis, Differential; Electrocardiography; Female; Humans; Long QT Syndrome; Quinidine; Radiofrequency Ablation; Torsades de Pointes; Treatment Outcome | 2021 |
Characteristics of electromechanical window in anesthetized rabbit models of short QT and long QT syndromes.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Benzopyrans; Biomarkers; Biomarkers, Pharmacological; Cromakalim; Disease Models, Animal; Electrocardiography; Isoflurane; Long QT Syndrome; Phenethylamines; Pinacidil; Quinidine; Rabbits; Risk; Sulfonamides; Systole; Torsades de Pointes; Ventricular Pressure | 2017 |
Analysis of unipolar electrograms in rabbit heart demonstrated the key role of ventricular apicobasal dispersion in arrhythmogenicity.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Arrhythmias, Cardiac; Chromans; Electrophysiologic Techniques, Cardiac; Endocardium; Pericardium; Quinidine; Rabbits; Sotalol; Sulfonamides; Torsades de Pointes | 2014 |
Role of late sodium current in modulating the proarrhythmic and antiarrhythmic effects of quinidine.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Ventricles; Myocytes, Cardiac; Quinidine; Rabbits; Sodium; Sodium Channels; Torsades de Pointes | 2008 |
The influence of progesterone alone and in combination with estradiol on ventricular action potential duration and triangulation in response to potassium channel inhibition.
Topics: Action Potentials; Animals; Dihydrotestosterone; Estradiol; Estrogen Replacement Therapy; Female; Heart Ventricles; Ovariectomy; Potassium Channel Blockers; Progesterone; Quinidine; Rabbits; Risk Assessment; Sex Factors; Time Factors; Torsades de Pointes | 2011 |
Torsades, sex hormones, and ventricular repolarization.
Topics: Action Potentials; Animals; Dihydrotestosterone; Estradiol; Estrogen Replacement Therapy; Female; Heart Ventricles; Humans; Male; Potassium Channel Blockers; Progesterone; Quinidine; Risk Assessment; Sex Factors; Time Factors; Torsades de Pointes | 2011 |
High risk of QT interval prolongation and torsades de pointes associated with intravenous quinidine used for treatment of resistant malaria or babesiosis.
Topics: Adolescent; Adult; Aged; Antimalarials; Arrhythmias, Cardiac; Babesiosis; Female; Heart; Heart Rate; Humans; Long QT Syndrome; Malaria; Male; Middle Aged; Quinidine; Risk Factors; Torsades de Pointes | 2012 |
Assessment of QT-prolonging drugs in the isolated normal and failing rabbit hearts.
Topics: Animals; Arrhythmias, Cardiac; Cisapride; Electrocardiography; Feasibility Studies; Glucose; Heart; Heart Failure; In Vitro Techniques; Male; Models, Animal; Phenethylamines; Quinidine; Rabbits; Sulfonamides; Torsades de Pointes; Tromethamine | 2012 |
Quinidine cardiotoxicity.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bradycardia; Drug Overdose; Electrocardiography; Female; Humans; Middle Aged; Quinidine; Torsades de Pointes | 2005 |
Use of a failing rabbit heart as a model to predict torsadogenicity.
Topics: Amiodarone; Animals; Cardiac Output, Low; Cisapride; Dose-Response Relationship, Drug; Electrocardiography; Models, Animal; Phenethylamines; Quaternary Ammonium Compounds; Quinidine; Rabbits; Sulfonamides; Torsades de Pointes; Verapamil | 2006 |
[Long QT syndrome induced by cordaron and quinidine].
Topics: Amiodarone; Anemia, Hemolytic; Anti-Arrhythmia Agents; Female; Humans; Hypertension; Long QT Syndrome; Middle Aged; Myocardial Ischemia; Quinidine; Torsades de Pointes; Ventricular Fibrillation | 2007 |
The long QT syndrome: when syncope is common to the young and the elderly.
Topics: Age of Onset; Aged; Anti-Arrhythmia Agents; Bradycardia; Child; Clinical Protocols; Female; Heart; Humans; Ion Channel Gating; Long QT Syndrome; Male; Quinidine; Stellate Ganglion; Syncope; Torsades de Pointes; Water-Electrolyte Imbalance | 1995 |
Quinidine but not disopyramide prolongs cardiac Purkinje fiber action potentials after a pause.
Topics: Action Potentials; Animals; Disopyramide; Dogs; Dose-Response Relationship, Drug; Electrodes, Implanted; In Vitro Techniques; Purkinje Fibers; Quinidine; Torsades de Pointes | 1994 |
"Late" proarrhythmia due to quinidine.
Topics: Aged; Aged, 80 and over; Atrial Fibrillation; Bradycardia; Drug Combinations; Electrocardiography; Female; Humans; Hypokalemia; Long QT Syndrome; Male; Middle Aged; Quinidine; Sick Sinus Syndrome; Time Factors; Torsades de Pointes | 1994 |
Differences in corrected QT intervals at minimal and maximal heart rate may identify patients at risk for torsades de pointes during treatment with antiarrhythmic drugs.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Electrocardiography; Female; Forecasting; Heart Rate; Humans; Male; Procainamide; Quinidine; Risk Factors; Sensitivity and Specificity; Torsades de Pointes | 1994 |
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Cardiomyopathy, Dilated; Drug Combinations; Female; Humans; Male; Middle Aged; Quinidine; Sotalol; Tachycardia; Torsades de Pointes; Ventricular Fibrillation | 1994 |
Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence.
Topics: Animals; Anti-Arrhythmia Agents; Cells, Cultured; Electrophysiology; Extracellular Space; Heart; Humans; Mice; Myocardium; Phenethylamines; Potassium; Quinidine; Sulfonamides; Torsades de Pointes | 1996 |
[Torsade de pointes during quinidine and amiodarone therapy].
Topics: Amiodarone; Catheter Ablation; Female; Humans; Middle Aged; Pacemaker, Artificial; Quinidine; Torsades de Pointes | 1996 |
Optical mapping of drug-induced polymorphic arrhythmias and torsade de pointes in the isolated rabbit heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrocardiography; Heart; Heart Conduction System; Image Processing, Computer-Assisted; Models, Cardiovascular; Organ Culture Techniques; Perfusion; Piperidines; Pyridines; Quinidine; Rabbits; Torsades de Pointes | 1997 |
[Torsade de pointes tachycardia during administration of quinidine and verapamil in atrial fibrillation].
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Combinations; Electrocardiography; Fatal Outcome; Female; Heart Arrest; Humans; Long QT Syndrome; Quinidine; Torsades de Pointes; Verapamil | 1997 |
Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Electrocardiography, Ambulatory; Female; Humans; Quinidine; Tachycardia, Ventricular; Torsades de Pointes | 1997 |
Combination of sotalol and quinidine in a canine model of torsades de pointes: no increase in the QT-related proarrhythmic action of sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Drug Therapy, Combination; Electrophysiology; Infusions, Intravenous; Quinidine; Sodium Chloride; Sotalol; Torsades de Pointes | 1998 |
Images in cardiovascular medicine. Labile repolarization from "cell to bedside".
Topics: Anti-Arrhythmia Agents; Antiemetics; Electric Countershock; Female; Humans; Long QT Syndrome; Middle Aged; Prochlorperazine; Quinidine; Recurrence; Retreatment; Torsades de Pointes | 2000 |
Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Anesthesia; Animals; Anti-Arrhythmia Agents; Blood Pressure; Delayed Rectifier Potassium Channels; Electrocardiography; Heart Rate; Male; Methoxamine; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Voltage-Gated; Quinidine; Rabbits; Terfenadine; Torsades de Pointes | 2000 |
Acute canine model for drug-induced Torsades de Pointes in drug safety evaluation-influences of anesthesia and validation with quinidine and astemizole.
Topics: Acute Disease; Anesthesia; Anesthetics, Inhalation; Animals; Astemizole; Atrioventricular Node; Catheter Ablation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electric Stimulation; Electrocardiography; Female; Halothane; Heart Block; Isoflurane; Long QT Syndrome; Male; Pentobarbital; Quinidine; Sensitivity and Specificity; Torsades de Pointes | 2001 |
Proarrhythmic effects of intravenous quinidine, amiodarone, D-sotalol, and almokalant in the anesthetized rabbit model of torsade de pointes.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Pressure; Electrocardiography; Heart Rate; Infusions, Intravenous; Male; Phenylephrine; Propanolamines; Quinidine; Rabbits; Sotalol; Torsades de Pointes | 2002 |
Precordial QT interval dispersion as a marker of torsade de pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Conduction System; Humans; Male; Middle Aged; Quinidine; Torsades de Pointes | 1992 |
Torsades de pointes and ventricular fibrillation in a canine model of quinidine-induced QT prolongation.
Topics: Animals; Bretylium Tosylate; Cardiac Pacing, Artificial; Dogs; Female; Heart Conduction System; Isoproterenol; Lidocaine; Long QT Syndrome; Male; Models, Cardiovascular; Quinidine; Torsades de Pointes; Ventricular Fibrillation | 1992 |
Propafenone-induced torsade de pointes: cross-reactivity with quinidine.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cross Reactions; Electrocardiography; Female; Humans; Propafenone; Quinidine; Torsades de Pointes | 1991 |
[A case from practice (234). Torsades de pointes under quinidine therapy and diuretic-induced hypokalemia. 2. Hypertension and coronary heart disease - tachycardia with atrial flutter - biventricular heart insufficiency - sick-sinus syndrome - 3. Arterial
Topics: Aged; Atrial Fibrillation; Coma; Diagnosis, Differential; Electrocardiography; Female; Humans; Hypertension; Hypokalemia; Quinidine; Sick Sinus Syndrome; Torsades de Pointes; Venous Insufficiency | 1991 |
[Torsades de Pointes: analysis of 105 episodes].
Topics: Aged; Diuretics; Electrocardiography, Ambulatory; Female; Humans; Male; Middle Aged; Quinidine; Retrospective Studies; Torsades de Pointes | 1991 |
Proarrhythmia: disparity of programmed electrical stimulation results and spontaneous occurrence: a case report.
Topics: Aged; Arrhythmias, Cardiac; Electric Stimulation; Electrocardiography; Female; Humans; Quinidine; Reproducibility of Results; Torsades de Pointes | 1991 |
The efficacy of isoproterenol on quinidine induced torsade de pointes.
Topics: Animals; Dogs; Electrocardiography; Electrophysiology; Isoproterenol; Quinidine; Torsades de Pointes | 1991 |
[Efficacy of isoproterenol, magnesium sulfate and verapamil for torsade de pointes].
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Electrocardiography; Isoproterenol; Magnesium Sulfate; Quinidine; Torsades de Pointes; Verapamil | 1991 |
Effect of magnesium sulfate on ventricular refractoriness and its efficacy for torsade de pointes.
Topics: Animals; Dogs; Drug Evaluation, Preclinical; Electric Stimulation; Heart Ventricles; Magnesium Sulfate; Quinidine; Torsades de Pointes; Ventricular Function, Left | 1990 |
[Torsade de pointes induced by quinidine: a case treated successfully with verapamil].
Topics: Adult; Atrial Fibrillation; Electrocardiography; Humans; Quinidine; Torsades de Pointes; Verapamil | 1990 |